Innovative nanotheranostics: Smart nanoparticles based approach to overcome breast cancer stem cells mediated chemo‐ and radioresistances
WIREs Nanomedicine and Nanobiotechnology · 2023
DOI: 10.1002/wnan.1876 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift WIREs Nanomedicine and Nanobiotechnology, 2023. Verfasst von Prithwish Kola und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical Science and Technology, Indian Institute of Technology Kharagpur, Kharagpur, India. Hauptthemen laut MEDLINE: Breast Neoplasms, Nanoparticles. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 372 Literaturangaben. Gefördert von: Ministry of Human Resource Development, Indian Institute of Technology Kharagpur, Indian Council of Medical Research.
Abstract (Originalsprache)
The alarming increase in the number of breast cancer patients worldwide and the increasing death rate indicate that the traditional and current medicines are insufficient to fight against it. The onset of chemo‐ and radioresistances and cancer stem cell‐based recurrence make this problem harder, and this hour needs a novel treatment approach. Competent nanoparticle‐based accurate drug delivery and cancer nanotheranostics like photothermal therapy, photodynamic therapy, chemodynamic therapy, and sonodynamic therapy can be the key to solving this problem due to their unique characteristics. These innovative formulations can be a better cargo with fewer side effects than the standard chemotherapy and can eliminate the stability problems associated with cancer immunotherapy. The nanotheranostic systems can kill the tumor cells and the resistant breast cancer stem cells by novel mechanisms like local hyperthermia and reactive oxygen species and prevent tumor recurrence. These theranostic systems can also combine with chemotherapy or immunotherapy approaches. These combining approaches can be the future of anticancer therapy, especially to overcome the breast cancer stem cells mediated chemo‐ and radioresistances. This review paper discusses several novel theranostic systems and smart nanoparticles, their mechanism of action, and their modifications with time. It explains their relevance and market scope in the current era. This article is categorized under: Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medical Science and Technology, Indian Institute of Technology Kharagpur, Kharagpur, India.
- Laboratory of Signal Transduction, Memorial Sloan Kettering Cancer Centre, New York, New York, USA.
- 3Bs Research Group, I3Bs-Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, Gui…
ORCID-Profile: Prithwish Kola, Prasanth Kumar Bhusetty Nagesh, Pritam Kumar Roy, K Deepak, Rui Luis Reis, Subhas C Kundu, Mahitosh Mandal
Förderung
- Ministry of Human Resource Development
- Indian Institute of Technology Kharagpur
- Indian Council of Medical Research
- Science and Engineering Research Board
Zitieren
APA
Kola, P., Nagesh, P. K. B., Roy, P. K., Deepak, K., Reis, R. L., Kundu, S. C., & Mandal, M. (2023). Innovative nanotheranostics: Smart nanoparticles based approach to overcome breast cancer stem cells mediated chemo‐ and radioresistances. WIREs Nanomedicine and Nanobiotechnology. https://doi.org/10.1002/wnan.1876
Vancouver
Kola P, Nagesh PKB, Roy PK, Deepak K, Reis RL, Kundu SC, et al. Innovative nanotheranostics: Smart nanoparticles based approach to overcome breast cancer stem cells mediated chemo‐ and radioresistances. WIREs Nanomedicine and Nanobiotechnology. 2023. doi:10.1002/wnan.1876
BibTeX
@article{Kola2023,
author = {Kola, Prithwish and Nagesh, Prasanth Kumar Bhusetty and Roy, Pritam Kumar and Deepak, K and Reis, Rui Luis and Kundu, Subhas C and Mandal, Mahitosh},
title = {Innovative nanotheranostics: Smart nanoparticles based approach to overcome breast cancer stem cells mediated chemo‐ and radioresistances},
journal = {WIREs Nanomedicine and Nanobiotechnology},
year = {2023},
doi = {10.1002/wnan.1876}
}
EUVIMED